Stock Events

Stock Events

Kymera Therapeutics (KYMR) Q1 2025 Earnings

27FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.88

-0.78

-0.68

-0.58

Details

Expected EPS

-0.774769

Actual EPS

-0.88

Surprise EPS

-0.11

Surprise Percent

+13.58%

Description

Kymera Therapeutics (KYMR) has reported earnings of -0.88 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.